How to Start Nitroglycerin (NTG) Injection
Intravenous NTG should be initiated at a rate of 10 mcg per minute through continuous infusion via nonabsorbing tubing and increased by 10 mcg per minute every 3 to 5 minutes until symptom relief or blood pressure response is noted. 1
Initial Setup and Dosing
- Begin IV NTG at 10 mcg/min via continuous infusion using nonabsorbing tubing 1
- Titrate upward by 10 mcg/min increments every 3-5 minutes until one of the following occurs:
Titration Algorithm
- If no response is seen at 20 mcg/min, continue with 10 mcg/min increments 1
- At higher doses, increments of 20 mcg/min may be used 1
- Once symptoms are relieved, no further dose increases are needed even if blood pressure hasn't changed significantly 1
- If symptoms persist, continue increasing until blood pressure response is observed 1
- When partial blood pressure response is observed, reduce the increment size and lengthen interval between increases 1
Maximum Dosing and Duration
- Although no official maximum dose is established, a ceiling of 200 mcg/min is commonly used 1
- Even prolonged infusion (2-4 weeks) at 300-400 mcg/min does not increase methemoglobin levels 1, 2
- Tolerance typically develops after 24 hours of continuous therapy 1
- For patients requiring NTG beyond 24 hours, periodic dose increases may be needed to maintain efficacy 1
Blood Pressure Parameters
- Do not titrate systolic BP below 110 mmHg in previously normotensive patients 1
- Do not reduce BP more than 25% below baseline mean arterial pressure in hypertensive patients 1
- Avoid NTG in patients with:
Contraindications and Precautions
- NTG is contraindicated after use of:
- Phosphodiesterase inhibitors can cause profound hypotension, MI, and even death when combined with nitrates 1
Transitioning from IV to Oral/Topical NTG
- When patients are free of ischemic symptoms for 12-24 hours, attempt to reduce IV NTG dose 1
- Convert to oral or topical nitrates within 24 hours in stabilized patients 1
- Use non-tolerance producing regimens (lower doses and intermittent dosing) 1
- Discontinue IV NTG in patients who remain free of signs and symptoms of ischemia 1
- If ischemia recurs during continuous therapy, increase dose and consider adding nitrate-free intervals 1
Managing Nitrate Tolerance
- Tolerance to hemodynamic effects is dose and duration dependent 1
- To minimize tolerance, use intermittent dosing schedules that provide nitrate-free intervals during each 24-hour period 3
- For recurrent ischemia during continuous therapy, responsiveness can often be restored by increasing the dose 1